Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Non Precious Metal Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN116478155A enables high-purity Grapiprant production with significant cost reduction and supply chain reliability for veterinary pharmaceutical manufacturers.
Patent CN112745256B reveals a novel non-Pd/C reduction route for Ropinirole intermediates. Achieve high purity and significant cost reduction in API manufacturing.
Solve 6-substituted phenanthridine synthesis challenges with non-precious metal catalysis. 85% yield, mild conditions, and scalable production for pharma R&D and procurement.